M K Proteins growth ratios

Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025
+43.0%+9.0%
−8.2%−25.2%
−9.1%−24.9%
−18.7%−25.1%
−18.2%−26.7%
+0.5%+35.7%
+9.8%+13.7%
+133.7%−149.8%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

MKPL₹3.65

M K Proteins Limited

· FMCG & Retail
₹ CrorePeersROMLHALDERNKINDGOKULKRITINUTSUNDROPMcap ₹137 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—+9.0+43.0—
EBITDA Growth—-25.2-8.2—
EBIT Growth—-24.9-9.1—
Net Income Growth—-25.1-18.7—
EPS Growth—-26.7-18.2—
Total Assets Growth—+35.7+0.5—
Total Equity Growth—+13.7+9.8—
Cash from Operations Growth—-149.8+133.7—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.